Biorchestra is a South Korea-based biotechnology company that develops and commercializes RNA therapies for the treatment of neurodegenerative and inflammatory diseases.
Business Model:
Revenue: $3M
Employees: 51-200
Address: Techno 4-ro, Yuseong-gu
City: Daejeon
State: daejeon gwang'yeogsi
Zip: 34013
Country: KR
Biorchestra is a South Korea-based biotechnology company that develops and commercializes RNA therapies for the treatment of neurodegenerative and inflammatory diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|---|---|---|---|
8/2019 | Series A | $4.1M |
Chong Kun Dang |
|
2/2022 | Series C | 12 | $45M |
Chong Kun Dang Pharmaceutical Corp. Dayli Partners E&a;Venture Partners GS Holdings IMM Investment LSK Investment NH Investment &a; Securities Quantum Ventures Korea SBI Investment Smilegate Investment STIC Investment Widwin Investment Chong Kun Dang Pharmaceutical Corp. Dayli Partners E&a;Venture Partners GS Holdings IMM Investment LSK Investment NH Investment &a; Securities Quantum Ventures Korea SBI Investment Smilegate Investment STIC Investment Widwin Investment |
11/2020 | Series B | $29.4M |
Chong Kun Dang Pharmaceutical |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|